Mary Carrington

Mary Carrington is a renowned biomedical scientist and professor known for her significant contributions to the field of human genetics and immunology. She is currently serving as the Director of the Basic Science Program at the Frederick National Laboratory for Cancer Research.

Early Life and Education[edit | edit source]

Carrington was born and raised in United States. She completed her undergraduate studies in biology at the University of California, Berkeley, and later pursued her doctoral degree in genetics from the Stanford University.

Career and Research[edit | edit source]

Carrington began her career as a research scientist at the National Cancer Institute (NCI), where she focused on the study of human leukocyte antigen (HLA) and killer-cell immunoglobulin-like receptor (KIR) genes. Her research has significantly contributed to the understanding of the role of these genes in immune response and susceptibility to various diseases including cancer, autoimmune diseases, and infectious diseases.

In 2012, Carrington was appointed as the Director of the Basic Science Program at the Frederick National Laboratory for Cancer Research. Under her leadership, the program has made significant advancements in the field of cancer research and genomic medicine.

Awards and Recognition[edit | edit source]

Carrington's work has been recognized with numerous awards and honors. She is a recipient of the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology and the American Association of Immunologists Lifetime Achievement Award.